by jennlbpak | Apr 14, 2025 | In the News
Paul M. George, MD, PhD, FAAN, Chair of the AAN Science Committee, discusses his selections for the most groundbreaking scientific research being presented at the 2025 AAN Annual Meeting, April 5-9 in San Diego. He was joined by the authors of three abstracts: Rajesh...
by jennlbpak | Apr 14, 2025 | In the News
SAN DIEGO — Neuromodulation of the sphenopalatine ganglion (SPG) through transnasal evaporative cooling is a promising nonpharmacologic treatment for acute migraine, results of a randomized controlled trial suggested. The SPG, a nerve bundle located behind the nasal...
by jennlbpak | Apr 10, 2025 | In the News
Conditioned room air delivered transnasally is safe, effective and tolerable for treatment of acute migraine, according to findings from a new study led by a Cleveland Clinic researcher. The results provide the first proof-of-concept for the Mi-Helper, a noninvasive...
by jennlbpak | Apr 8, 2025 | In the News
SAN DIEGO — An investigational device that delivered conditioned room air intranasally treated acute migraine attacks without drugs, a randomized sham-controlled study showed. Compared with sham, transnasal dry air flow at 10 L per minute using the Mi-Helper...
by jennlbpak | Apr 7, 2025 | In the News
SAN DIEGO — Significantly more patients with acute migraine who received a 10 L per minute dose of a transnasal cooling device had pain freedom at 2 hours vs. those who received sham, according to research presented at the AAN Annual Meeting. “There is a critical need...
by jennlbpak | Aug 1, 2023 | In the News
By Marc Lallanilla – Read More Published Aug. 1, 2023 | Updated Aug. 1, 2023, 5:02 p.m. ET An innovative new treatment might soon help millions of people worldwide who suffer from migraines. Researchers have used a device that delivers a stream of air...
